The learning curve for sentinel node biopsy in breast cancer: Practical considerations

Archives of Surgery

Volumn 134, Issue 7, 1999, Pages 764-767

  Orr, Richard K ^a,b,d   Hoehn, James L ^a,b   Col, Nananda F ^c  

^a MARSHFIELD CLINIC   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Gibbs Cancer Center and Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER STAGING; CANCER SURVIVAL; CLINICAL EDUCATION; CLINICAL PRACTICE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; FEMALE; HEALTH CARE COST; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECURRENT CANCER;

BIOPSY; BREAST NEOPLASMS; CLINICAL COMPETENCE; COSTS AND COST ANALYSIS; DECISION SUPPORT TECHNIQUES; FEMALE; HUMANS; LYMPHATIC METASTASIS; NEOPLASM STAGING; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE;

EID: 0033054579     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.134.7.764     Document Type: Article

References (37)

1. Cady B, Stone MD, Wayne J. New therapeutic possibilities in primary invasive breast cancer. Ann Surg. 1993;218:338-349.
2. Deckers PJ. Axillary dissection in breast cancer: when, why, how much, and for how long? another operation soon to be extinct? J Surg Oncol. 1991;48:217-219.
3. Morton DL, Wen D-R, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early-stage melanoma. Arch Surg. 1992;127:392-399.
4. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol. 1993;2:335-340.
5. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220:391-401.
6. Turner RR, Ollila DW, Krasne DL, Giuliano AE. Histopathologic validation of the sentinel lymph node hypothesis for breast cancer. Ann Surg. 1997;226:271-278.
7. Guenther JM, Krishnamoorthy M, Tan LT. Sentinel lymphadenectomy for breast cancer in a community managed care setting. Cancer J Sci Am. 1997;3:336-340.
8. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol. 1997;15:2345-2350.
9. Rodier JF, Janser JC. Surgical technical details improving sentinel node identification in breast cancer. Oncol Rep. 1997;4:281-283.
10. Dale PS, Williams JT. Axillary staging utilizing selective sentinel lymphadenectomy for patients with invasive breast cancer. Am Surg. 1998;64:28-32.
11. Flett MM, Going JJ, Stanton PD, Cooke TG. Sentinel node localization in patients with breast cancer. Br J Surg. 1998;85:991-993.
12. Pijpers R, Meijer S, Hoekstra OS, et al. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloid albumin in breast cancer. J Nucl Med. 1997;38:366-368.
13. Roumen RMH, Valkenberg JGM, Geuskens LM. Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast cancer. Eur J Surg Oncol. 1997;23:495-502.
14. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet. 1997; 349:1864-1867.
15. Borgstein PJ, Pijpers R, Comans EF, et al. Sentinel node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg. 1998;186:275-283.
16. Crossin JA, Johnson C, Stewart PB, Turner WW Jr. γ-Probe-guide resection of the sentinel lymph node in breast cancer. Am Surg. 1998;64:666-669.
17. Krag D, Harlow S, Weaver D, Ashikaga T. Technique of sentinel node resection in melanoma and breast cancer: probe-guided surgery and lymphatic mapping. Eur J Surg Oncol. 1998;24:89-93.
18. Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA. 1996;276:1818-1822.
19. Barnwell JM, Arrendondo MA, Kollmorgen D, et al. Sentinel node biopsy in breast cancer. Ann Surg Oncol. 1998;5:126-130.
20. Cox CE, Pendas S, Cox JM, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg. 1998;227:645-653.
21. O'Hea BJ, Hill ADK, El-Shirbiny AM, et al. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. JAm Coll Surg. 1998;186:423-427.
22. Morton DL. Intraoperative lymphatic mapping and sentinel lymphadenectomy: community standard of care or clinical investigation? Cancer J Sci Am. 1997;3: 328-329.
23. Reintgen D. The credentialing of American Surgery [reply letter]. Ann Surg Oncol. 1997;4:603.
24. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet. 1992;339:1-15, 71-85.
25. Beck R, Kassirer JP, Pauker SG. Convenient approximation of life expectancy (the DEALE): validation of the method. Am J Med. 1982;73:883-888.
26. Orr RK. The impact of prophylactic axillary node dissection on breast cancer survival: a Bayesian meta-analysis. Ann Surg Oncol. 1999;6:109-116.
27. Fisher B, Redmond C, Fisher ER, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med. 1985;312:674-681.
28. Cady B. The need to reexamine axillary lymph node dissection in invasive breast cancer. Cancer. 1994;73:505-507.
29. Goodman AA, Mendez AL. Definitive surgery for breast cancer performed on an outpatient basis. Arch Surg. 1993;128:1149-1152.
30. Orr RK, Col NF. Should axillary node dissection be routine in post-menopausal women? a cost-effectiveness analysis of ER+ lumpectomy patients. Breast Cancer Res Treat. 1994;32(suppl):92.
31. Hillner BE, Smith TJ. A model of chemotherapy in node-negative breast cancer. Natl Cancer Inst Monogr. 1992;11:143-149.
32. Velanovich V. Axillary lymph node dissection for breast cancer: a decision analysis of T1 lesions. Ann Surg Oncol. 1998;5:131-139.
33. Forrest APM, Everington D, McDonald CC, Steele RJC, Chetty U, Stewart HJ. The Edinburgh randomized trial of axillary sampling or clearance after mastectomy. Br J Surg. 1995;82:1504-1508.
34. Sosa JA, Diener-West M, Gusev Y, et al. Association between extent of axillary lymph node dissection and survival in patients with stage I breast cancer. Ann Surg Oncol. 1998;5:140-149.
35. Sequeira R, Weinbaum F, Satterfield J, Chassin J, Mock L. Credentialing physicians for new technology: the physician's learning curve must not harm the patient. Am Surg. 1994;60:821-823.
36. Gates EA. New surgical procedures: can our patients benefit while we learn? Am J Obstet Gynecol. 1997;176:1293-1299.
37. Copeland EM. In discussion of: Cox CE, Pendas S, Cox JM, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg. 1998;227:651.